Key facts
- It has raised $81.0M across 8 recorded rounds; the latest was Later Stage VC (Series D1) ($81.0M) in Mar 2021.
- Rapid Micro Biosystems has filed 9 Form Ds with the SEC since 2009, most recently Aug 2019 ($60.0M sold to 11 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 8 rounds
- ·Watchlist + deal alerts for Rapid Micro Biosystems
Create free account
No card required
Funding rounds
8 roundsMar 2021Later Stage VC (Series D1)$81.0M▮
About Rapid Micro Biosystems
- Industry
- Biotechnology
PA Mark — not yet priced
Rapid Micro Biosystems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Rapid Micro Biosystems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Rapid Micro Biosystems in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.